CSat Investment Advisory’s AbbVie ABBV Stock Holding History

CSat Investment Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$3K	Sell	30 -2	-6%	-$214	﹤0.01%	504
2020 Q4	$3K	Sell	32 -7,381	-100%	-$709K	﹤0.01%	501
2020 Q3	$649K	Buy	7,413 +1,004	+16%	+$94.5K	0.06%	159
2020 Q2	$629K	Buy	6,409 +2,160	+51%	+$190K	0.08%	141
2020 Q1	$324K	Sell	4,249 -102	-2%	-$8.69K	0.07%	179
2019 Q4	$386K	Buy	4,351 +1,216	+39%	+$101K	0.1%	178
2019 Q3	$238K	Buy	3,135 +412	+15%	+$28.2K	0.07%	186
2019 Q2	$198K	Buy	2,723 +2,693	+8,977%	+$212K	0.07%	189
2019 Q1	$2K	Buy	30 +4	+15%	+$327	﹤0.01%	537
2018 Q4	$2K	Buy	26 +13	+100%	+$1.14K	﹤0.01%	522
2018 Q3	$1K	Buy	13 +2	+18%	+$190	﹤0.01%	539
2018 Q2	$1K	Buy	+11	New	+$1.07K	﹤0.01%	539

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CSat Investment Advisory's ABBV Position: Q1 2021 in Review

CSat Investment Advisory reduced its AbbVie (ABBV) stake by 6.3% in Q1 2021, selling an estimated $214 and leaving 30 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

CSat Investment Advisory first reported a position in ABBV in Q2 2018 and has held it in 12 quarters since. The position peaked at $649K in Q3 2020. 2,615 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

CSat Investment Advisory held 30 shares of AbbVie worth $3K as of Q1 2021.
CSat Investment Advisory sold 2 AbbVie shares in Q1 2021, an estimated $214.
AbbVie made up ﹤0.01% of CSat Investment Advisory's portfolio in Q1 2021, its #504 holding.
CSat Investment Advisory first reported a position in AbbVie in Q2 2018 and has held it in 12 quarters since.
CSat Investment Advisory's AbbVie position peaked at $649K in Q3 2020.
2,615 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.